Symrise AG

SY1

DE000SYM9999

Specialty Chemicals

Market Closed - Xetra Other stock markets 11:35:08 2024-05-06 am EDT			After market 03:59:37 pm
101.2 ^EUR	+0.40%		101.6	+0.42%

Apr. 29	SYMRISE AG : Warburg Research gives a Neutral rating	ZD
Apr. 26	SYMRISE AG : Gets a Buy rating from Baader Bank	ZD

SYMRISE AG : Goldman Sachs reiterates its Sell rating

April 26, 2024 at 05:45 am EDT

Goldman Sachs analyst Georgina Fraser reiterate his Sell rating on the stock. The target price is lowered from EUR 101 to EUR 97.

Latest news about Symrise AG

SYMRISE AG : Warburg Research gives a Neutral rating	Apr. 29	ZD
SYMRISE AG : Gets a Buy rating from Baader Bank	Apr. 26	ZD
SYMRISE AG : DZ Bank reiterates its Neutral rating	Apr. 26	ZD
SYMRISE AG : Goldman Sachs reiterates its Sell rating	Apr. 26	ZD
SYMRISE AG : UBS reiterates its Buy rating	Apr. 26	ZD
SYMRISE AG : Baader Bank remains its Buy rating	Apr. 25	ZD
SYMRISE AG : UBS gives a Buy rating	Apr. 25	ZD
Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15	Apr. 25	DP
SYMRISE AG : Goldman Sachs keeps a Sell rating	Apr. 25	ZD
SYMRISE AG : Warburg Research reiterates its Neutral rating	Apr. 25	ZD
SYMRISE AG : Barclays gives a Neutral rating	Apr. 25	ZD
Symrise disappoints despite strong sales growth	Apr. 25	DP
SYMRISE AG : JP Morgan gives a Buy rating	Apr. 25	ZD
SYMRISE AG : Buy rating from Jefferies	Apr. 25	ZD
ROUDUP: Symrise grows strongly at the start of the year - investors nevertheless somewhat disappointed	Apr. 25	DP
Symrise prematurely weak - Jefferies: Bar high	Apr. 25	DP
Symrise posts quarterly sales above expectations	Apr. 25	RE
SYMRISE AG : Barclays reaffirms its Neutral rating	Apr. 22	ZD
SYMRISE AG : Gets a Neutral rating from Barclays	Apr. 08	ZD
SYMRISE AG : Gets a Neutral rating from Deutsche Bank	Apr. 05	ZD
SYMRISE AG : UBS reiterates its Buy rating	Apr. 03	ZD
Goldman raises target for Symrise to 101 euros - 'Sell'	Mar. 28	DP
SYMRISE AG : Gets a Sell rating from Goldman Sachs	Mar. 28	ZD
SYMRISE AG : DZ Bank reiterates its Neutral rating	Mar. 27	ZD
SYMRISE AG : Goldman Sachs keeps a Sell rating	Mar. 26	ZD

Symrise AG is one of the world's leaders in developing, producing and marketing scents, flavors and functional ingredients. Net sales break down by family of products as follows: - nutritional ingredients (63%): for use in the manufacture of food products (beverages, candies, chocolates, cereals, dairy products, snacks, sauces, instant noodles, etc.) and in the manufacture of animal and fish feed; - perfumes and flavours (37%): perfumes, menthols, aromatic ingredients and chemicals for personal care products, oral care products, cleaning products, cosmetics, etc. Net sales are distributed geographically as follows: Germany (8.1%), Europe/Middle East/Africa (31.6%), the United States (24.4%), North America (2.1%), Asia/Pacific (20.7%) and Latin America (13.1%).

Sector

Specialty Chemicals

Calendar

2024-05-15 - Annual General Meeting

Related indices

STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Ratings for Symrise AG

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

100.8 EUR

Average target price

113.5 EUR

Spread / Average Target

+12.67%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
SYMRISE AG	+1.52%	15.17B
ECOLAB INC.	+15.43%	64.97B
SIKA AG	-1.42%	47.76B
GIVAUDAN SA	+14.49%	40.72B
FUJIFILM HOLDINGS CORPORATION	+20.84%	26.88B
EMS-CHEMIE HOLDING AG	+9.40%	19.29B
CELANESE CORPORATION	+2.39%	17.53B
POSCO FUTURE M CO., LTD.	-21.87%	16.03B
ALBEMARLE CORPORATION	-9.48%	15.06B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-20.36%	13.62B

Other Specialty Chemicals

Symrise AG

Equities

SY1

DE000SYM9999

Specialty Chemicals

SYMRISE AG : Goldman Sachs reiterates its Sell rating

Latest news about Symrise AG

Chart Symrise AG

Company Profile

Income Statement Evolution

Ratings for Symrise AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Specialty Chemicals